Your browser doesn't support javascript.
loading
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda.
Ngabonziza, J-C S; Habimana, Y M; Decroo, T; Migambi, P; Dushime, A; Mazarati, J B; Rigouts, L; Affolabi, D; Ivan, E; Meehan, C J; Van Deun, A; Fissette, K; Habiyambere, I; Nyaruhirira, A U; Turate, I; Semahore, J M; Ndjeka, N; Muvunyi, C M; Condo, J U; Gasana, M; Hasker, E; Torrea, G; de Jong, B C.
  • Ngabonziza JS; National Reference Laboratory Division, Department of Biomedical Services, Rwanda Biomedical Centre, Kigali, Rwanda, Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Habimana YM; Tuberculosis and Other Respiratory Diseases Division, Institute of HIV/AIDS Disease Prevention and Control, Rwanda Biomedical Centre, Kigali, Rwanda.
  • Decroo T; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium, Research Foundation Flanders, Brussels, Belgium.
  • Migambi P; Tuberculosis and Other Respiratory Diseases Division, Institute of HIV/AIDS Disease Prevention and Control, Rwanda Biomedical Centre, Kigali, Rwanda.
  • Dushime A; Tuberculosis and Other Respiratory Diseases Division, Institute of HIV/AIDS Disease Prevention and Control, Rwanda Biomedical Centre, Kigali, Rwanda.
  • Mazarati JB; Department of Biomedical Services, Rwanda Biomedical Centre, Kigali, Rwanda.
  • Rigouts L; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
  • Affolabi D; Laboratoire de Référence des Mycobactéries, Cotonou, Benin.
  • Ivan E; National Reference Laboratory Division, Department of Biomedical Services, Rwanda Biomedical Centre, Kigali, Rwanda.
  • Meehan CJ; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, School of Chemistry and Biosciences, University of Bradford, Bradford, UK.
  • Van Deun A; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, International Union Against Tuberculosis and Lung Disease, Paris, France.
  • Fissette K; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp.
  • Habiyambere I; Tuberculosis and Other Respiratory Diseases Division, Institute of HIV/AIDS Disease Prevention and Control, Rwanda Biomedical Centre, Kigali, Rwanda.
  • Nyaruhirira AU; Management Sciences for Health, Pretoria, South Africa.
  • Turate I; Institute of HIV/AIDS Disease Prevention and Control, Rwanda Biomedical Centre, Kigali.
  • Semahore JM; HIV, STIs, Hepatitis and Tuberculosis Programmes, World Health Organization Country Office, Kigali, Rwanda.
  • Ndjeka N; National Tuberculosis Programme, National Department of Health, Pretoria, South Africa.
  • Muvunyi CM; Department of Clinical Biology, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali.
  • Condo JU; Rwanda Biomedical Centre, Kigali, Rwanda.
  • Gasana M; Tuberculosis and Other Respiratory Diseases Division, Institute of HIV/AIDS Disease Prevention and Control, Rwanda Biomedical Centre, Kigali, Rwanda.
  • Hasker E; Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
  • Torrea G; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp.
  • de Jong BC; Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp.
Int J Tuberc Lung Dis ; 24(3): 329-339, 2020 03 01.
Article en En | MEDLINE | ID: mdl-32228764

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans País como asunto: Africa Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans País como asunto: Africa Idioma: En Año: 2020 Tipo del documento: Article